SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-081523
Filing Date
2024-07-03
Accepted
2024-07-03 16:15:07
Documents
2
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1589
2 EX-24 ck0001651311-ex24.htm EX-24 17027
  Complete submission text file 0000950170-24-081523.txt   20086
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM
Business Address
Zohren Fabian (Reporting) CIK: 0002029383 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37773 | Film No.: 241100290